Improving safety in post-cardiac surgical recovery
We're transforming temporary cardiac pacing
Cardiac Tech Ltd is a MedTech company that is creating a new safety paradigm in temporary pacing. The company’s technology is anticipated to substantially improve patient outcome and mortality post-cardiac surgery.
Having received backing from venture builders Start Codon, the company is focussed on developing its technology to deliver a new standard in patient care.
Meet the team
Founder & Inventor
Dan Meese is the inventor of the Pace-Protect device. Dan is an experienced cardiac physiologist with over 12 years’ clinical involvement in cardiac rhythm management and an in-depth understanding of the issues surrounding post-surgical temporary pacing. Dan has published journal articles and regularly presented to peers around both the UK and the US about temporary pacing, the dangers associated with it and the importance of proper management. He currently holds the position of Chief Cardiac Physiologist within the NHS, specialising in complex rhythm management and has worked in this role in some of the UK’s leading cardiac centres.
Will Simpson is a medical device professional with a history of successfully bringing new products to market. Will has previously built ISO 13485 Quality Management Systems and engaged with Notified/Approved Bodies to CE and UKCA mark (certify) new products. Will has experience with the regulations governing electrical safety, EMC, software lifecycle and risk management, specifically in the field of medical devices.
Bob joined Cardiac Tech Ltd as Chairman in April 2023 and brings with him a raft of skills and expertise in the navigation of the Med-tech landscape. He is an accomplished Chair, NED, and CEO with over 30 years of board experience within a mixture of early-stage start-ups and big cooperates. He has been part of seven successful exits, including with Reverse Medical who were acquired by Medtronic.
Prior to his broad experience, as the CEO of Vascular Dynamics he took the company through series A & B funding rounds raising $33m as well assisting in guiding the company to receive one of nine slots for the FDA fast track IDE program. As the COO of Micrus Endovascular, he led the company through their initial and secondary IPOs.
James joined Cardiac Tech Ltd as a Non-executive director in Feb 2023 to assist in developing the business, refining its strategy and direction. James has been involved in bringing new technology and products to market over the last 30 years and has held senior management positions and leadership roles in deep-tech organizations from start-ups to multinationals. He most recently co-founded Photonstar LED group plc an AIM listed LED lighting business which he led for 10 years.
James is a Member of the Institute of Directors, Society of Light and Lighting, a Fellow of the Institute of Physics, a Chartered Engineer and Chartered Physicist. James was also elected as Vice President of Business for the Institute of Physics (IOP) and was a trustee of the IOP from 2016-2020. James also served as Chair of the IOP Audit and Risk committee from 2019-2023.
Board of advisors
Cardiac Tech ltd is supported by a Board of Advisors that includes specialists in Cardiac Rhythm Management and Electrophysiology, Acute medicine, as well as Industry experts.
The Company has partnered with an accomplished electronic and software consultancy who are assisting with the development of the Company’s novel technology.